Derya Unutmaz, an immunologist, shares how AI, particularly Codex, is transforming biological research, from building custom cell analysis tools and T-cell simulators to envisioning a future of digital twins and personalized medicine, highlighting a coming "Science 2.0" paradigm.
Laura Deming, co-founder and CEO of Until, discusses the ambitious goal of making reversible cryopreservation a reality. She outlines the company's vision, starting with preserving human organs to revolutionize transplantation and progressing towards whole-body medical hibernation, allowing patients to "pause" biological time and await future cures. The conversation delves into the core scientific challenges, reframing cryopreservation as an engineering problem of heat transfer and managing ice formation, and explores why this promising field has been historically underfunded.